MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment

Published:2015-07-20 Issue:5 Volume:13 Page:658-668
ISSN:1672-7681
Container-title:Cellular & Molecular Immunology
language:en
Short-container-title:Cell Mol Immunol

Author:

He Hua,Yao Maojin,Zhang Wenhao,Tao Bangbao,Liu Feili,Li Shu,Dong Yan,Zhang Chenran,Meng Yicheng,Li Yuxin,Hu Guohan,Luo Chun,Zong Hui,Lu Yicheng

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/cmi201546.pdf

Reference42 articles.

1. Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O et al . Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 2012 ; 338 : 1080 – 1084 .

2. Chen S, Tanaka S, Giannini C, Morris J, Yan ES, Buckner J et al . Gliomatosis cerebri: clinical characteristics, management, and outcomes. J Neurooncol 2013 ; 112 : 267 – 275 .

3. Zhao J, He H, Zhou K, Ren Y, Shi Z, Wu Z et al . Neuronal transcription factors induce conversion of human glioma cells to neurons and inhibit tumorigenesis. PLoS One 2012 ; 7 : e41506 .

4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005 ; 352 : 987 – 996 .

5. Corsa P, Parisi S, Raguso A, Troiano M, Perrone A, Cossa S et al . Temozolomide and radiotherapy as first-line treatment of high-grade gliomas. Tumori 2006 ; 92 : 299 – 305 .

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring neuroadaptive cellular pathways in chronic morphine exposure: An in‐vitro analysis of cabergoline and Mdivi‐1 co‐treatment effects on the autophagy–apoptosis axis;Journal of Cellular Biochemistry;2024-04-05

2. Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings;Brain Sciences;2023-11-17

3. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies;International Journal of Molecular Sciences;2023-06-21

4. Potassium Ion Channels in Glioma: From Basic Knowledge into Therapeutic Applications;Membranes;2023-04-15

5. Frequent Epigenetic Inactivation of DIRAS-1 and DIRAS-2 Contributes to Chemo-Resistance in Gliomas;Cancers;2021-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3